RAFAEL BELTRAN DURANGO: Open Payments
NPI 1093807075 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,342 in 89 payments from 17 companies in 2025. Trend: 2023 $2,540 · 2024 $2,076 · 2025 $2,342
Food & beverage: $2,342
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 19 | $558 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $398 |
| ABBVIE INC. | 11 | $319 |
| E.R. Squibb & Sons, L.L.C. | 5 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $182 |
| Supernus Pharmaceuticals, Inc. | 4 | $145 |
| Alkermes, Inc. | 5 | $118 |
| Tris Pharma Inc | 5 | $102 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
Products named: Auvelity, TRINTELLIX, VRAYLAR, COBENFY, CAPLYTA, Qelbree, ARISTADA, Dyanavel XR.
Industry payments across FL — which companies pay providers there.
